bf/NYSE:AGL_icon.png

COM:AGILONHEALTH

agilon health

  • Stock

USD

Last Close

1.78

22/11 21:00

Market Cap

2.32B

Beta: -

Volume Today

2.78M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
5.30M
-
5.30M
0%
average payables
224.19M
-
306.04M
36.51%
441.03M
44.11%
265.05M
39.90%
average receivables
118.90M
-
218.98M
84.17%
395.49M
80.60%
720.02M
82.06%
book value per share
-0.60
-
-0.74
22.45%
2.93
495.73%
2.55
12.87%
1.62
36.55%
capex per share
-0.01
-
-0.01
39.96%
-0.04
489.56%
-0.08
122.27%
-0.04
51.62%
capex to depreciation
-0.09
-
-0.17
76.72%
-0.92
449.08%
-2.37
159.13%
-0.79
66.89%
capex to operating cash flow
0.04
-
0.04
17.45%
0.09
105.16%
0.25
175.53%
0.10
59.41%
capex to revenue
-0.00
-
-0.00
60.77%
-0.01
279.62%
-0.01
64.70%
-0.00
69.59%
cash per share
0.32
-
0.28
13.80%
2.79
904.95%
2.23
20.14%
1.19
46.38%
days of inventory on hand
1.49
-
days payables outstanding
89.72
-
84.45
5.87%
73.11
13.43%
74.53
1.95%
days sales outstanding
42.85
-
43.31
1.08%
58.41
34.87%
67.06
14.82%
79.70
18.84%
debt to assets
0.19
-
0.16
15.21%
0.03
81.40%
0.03
16.05%
0.02
13.53%
debt to equity
-0.34
-
-0.26
23.43%
0.04
117.24%
0.04
5.79%
0.06
39.51%
dividend yield
earnings yield
-0.01
-
-0.01
44.89%
-0.04
660.06%
-0.02
59.72%
-0.05
215.68%
enterprise value
11.86B
-
11.90B
0.32%
9.08B
23.70%
6.13B
32.43%
5.06B
17.46%
enterprise value over ebitda
-184.70
-
-296.60
60.58%
-23.65
92.03%
-63.60
168.90%
-19.92
68.69%
ev to operating cash flow
-114.18
-
-223.60
95.83%
-61.27
72.60%
-46.89
23.46%
-32.41
30.88%
ev to sales
14.93
-
9.76
34.59%
4.95
49.30%
2.26
54.25%
1.17
48.21%
free cash flow per share
-0.28
-
-0.14
48.56%
-0.43
200.15%
-0.40
7.56%
-0.42
5.04%
free cash flow yield
-0.01
-
-0.00
48.56%
-0.02
244.61%
-0.02
54.63%
-0.03
35.09%
graham net net
-1.15
-
-1.34
16.67%
2.05
253.11%
1.54
24.73%
0.28
81.74%
graham number
2.01
-
1.65
17.85%
8.46
411.83%
3.88
54.19%
4.84
24.79%
income quality
0.37
-
0.89
141.19%
0.36
58.89%
1.22
236.08%
0.59
51.44%
intangibles to total assets
0.28
-
0.23
18.31%
0.06
73.26%
0.06
5.29%
0.05
21.52%
interest coverage
-11.75
-
-6.97
40.72%
-64.10
820.09%
24.36
138.00%
34.87
43.14%
interest debt per share
0.23
-
0.21
6.68%
0.15
30.81%
0.10
34.74%
0.08
18.27%
inventory turnover
244.67
-
invested capital
-0.34
-
-0.26
23.43%
0.04
117.24%
0.04
5.79%
0.06
39.51%
market cap
11.90B
-
11.93B
0.21%
10.07B
15.60%
6.59B
34.58%
5.13B
22.10%
net current asset value
-389.29M
-
-436.89M
12.23%
872.54M
299.71%
794.41M
8.95%
400.23M
49.62%
net debt to ebitda
0.71
-
0.84
17.60%
2.58
208.61%
4.70
82.02%
0.27
94.23%
net income per share
-0.30
-
-0.16
44.89%
-1.09
561.99%
-0.26
75.92%
-0.64
145.46%
operating cash flow per share
-0.27
-
-0.14
48.88%
-0.40
187.36%
-0.32
19.33%
-0.38
19.19%
payables turnover
4.07
-
4.32
6.23%
4.99
15.51%
4.90
1.91%
receivables turnover
8.52
-
8.43
1.06%
6.25
25.85%
5.44
12.90%
4.58
15.85%
research and ddevelopement to revenue
return on tangible assets
-0.39
-
-0.18
53.47%
-0.27
48.33%
-0.07
75.29%
-0.16
136.29%
revenue per share
2.07
-
3.17
53.04%
4.92
55.30%
6.64
34.96%
10.56
59.08%
roe
0.49
-
0.22
55.00%
-0.37
267.28%
-0.10
72.36%
-0.40
286.89%
roic
0.73
-
0.28
61.62%
-0.34
223.28%
-0.10
70.39%
-0.33
224.22%
sales general and administrative to revenue
0.15
-
0.11
27.12%
0.25
120.61%
0.08
67.48%
0.07
18.11%
shareholders equity per share
-0.60
-
-0.74
22.45%
2.93
495.73%
2.55
12.87%
1.62
36.55%
stock based compensation to revenue
0.01
-
0.01
16.54%
0.16
2,804.98%
0.01
93.43%
0.02
53.64%
tangible asset value
-344.71M
-
-386.74M
12.19%
994.66M
357.19%
931.39M
6.36%
573.12M
38.47%
tangible book value per share
-0.90
-
-1.00
11.95%
2.67
365.40%
2.28
14.44%
1.40
38.58%
working capital
45.92M
-
27.36M
40.41%
1.01B
3,592.11%
916.18M
9.31%
502.92M
45.11%

All numbers in USD (except ratios and percentages)